A non-NIH clinical trial is now testing ivermectin, the antiparasitic drug that became a lightning rod during the COVID-19 pandemic, as a potential weapon against one of the most aggressive forms of ...

Scientists at Université de Montreal and its Institute for Research in Immunology and Cancer have begun a phase-1 clinical trial for a small-molecule therapy for solid tumors. Subscribe to our ...